SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000891554-01-501923
Filing Date
2001-04-04
Accepted
2001-04-04 00:00:00
Documents
2
Period of Report
2001-05-17

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT d70443_def14a.htm DEF 14A 158901
2 GRAPHIC performance_graph.gif GRAPHIC 16011
  Complete submission text file 0000891554-01-501923.txt   176491
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PKWY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 1594925
SIC: 2836 Biological Products, (No Diagnostic Substances)